Merck Can't Boot Witnesses From Bellwether Fosamax Trial

Law360, New York (April 11, 2013, 2:33 PM EDT) -- A New Jersey federal judge on Wednesday denied Merck & Co.'s bid to block the testimony of eight doctors in the first trial over femur fractures allegedly caused by its bone drug Fosamax, but said the plaintiff's treating physicians may not discuss general causation.

U.S. District Judge Joel A. Pisano rejected Merck's arguments that four expert witnesses called by plaintiff Bernadette Glynn are unqualified to testify on the purported connection between Fosamax and a femoral fractures in the bellwether trial, which opened in New Jersey federal...
To view the full article, register now.